BRSS 9th Annual Meeting

SCIENTIFIC PROGRAMME to include:

Geometric and dosimetric uncertainties in SRS: How accurate are we?
Open masks (vs closed) & relocatable masks (vs fixed frames) – how much flexibility benefits the patient?
HyperArc: A leap forward in technical capability or marketing?
Methods and frequency of patient specific QA – what is appropriate?
Combining SRS and systemic therapies: synergies and risks
Repeat SRS for metastases
– Treatment of large metastases
– SRS before or after surgery?
Fractionation vs staged
Progression/Pseudoprogression/Radionecrosis: Strategies for discernment
What’s the technical limit for the maximum number of mets we can treat?
– Gamma Knife
– Cyberknife
– Linac
SRS Trial development